Perceptive Advisors’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$10.9M Hold
2024
Q4
$32.3M Hold
2024
Q3
$37.5M Hold
2024
Q2
$31.1M Buy
2024
Q1
$21.5M Hold
2023
Q4
$14.8M Hold
2023
Q3
$28.8M Hold
2023
Q2
$39M Hold
2023
Q1
$38.2M Hold
2022
Q4
$34.7M Buy